| Doramapimod | IC50 | 30000.0 [1] |
| 7-Hydroxy-2,3,4,5-tetrahydro-1H-benzofuro[2,3-c]azepin-1-one | IC50 | 280.0 [1] |
| JNK Inhibitor VIII | Ki | 5300.0 [1] |
| CID 53246941 | IC50 | 139.0 [1] |
| CID 59604787 | IC50 | 10000.0 [1] |
| Bpkdi | IC50 | 9.0 [1] |
| N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)acetamide | Ki | 2500.0 [1] |
| 4-Amino-5-chloro-6-ethoxy-pyridine-2-carboxylic acid 4-methanesulfonyl-benzylamide | Ki | 5200.0 [1] |
| 7-Chloro-3-oxo-8-(1,3-thiazol-5-ylmethylamino)-11,16-dioxa-2,4,19,21-tetrazatricyclo[15.3.1.05,10]henicosa-1(20),5,7,9,17(21),18-hexaene-18-carbonitrile | Ki | 8980.0 [1] |
| 1-({4-[(3,4-Dichlorophenyl)methoxy]phenyl}methyl)azetidine-3-carboxylic acid | IC50 | 10000.0 [1] |
| 7-Chloro-8-(3-hydroxypropoxy)-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5,7,9,18(22),19-hexaene-19-carbonitrile | Ki | 10000.0 [1] |
| 7-Chloro-8-(3-hydroxypropyl)-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5(10),6,8,18(22),19-hexaene-19-carbonitrile | Ki | 10000.0 [1] |
| N-(7-Chloro-19-cyano-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5,7,9,18(22),19-hexaen-8-yl)methanesulfonamide | Ki | 10000.0 [1] |
| N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)-2-(2,5-dimethoxy-4-methylsulfonylphenyl)acetamide | Ki | 9000.0 [1] |
| N-(4-Amino-5-chloro-6-ethoxypyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxyphenyl)acetamide | Ki | 9000.0 [1] |
| N-(4-Amino-5-cyano-6-isopropoxypyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxyphenyl)acetamide | Ki | 950.0 [1] |
| N-(4-Amino-5-cyano-6-phenylpyridin-2-yl)acetamide | Ki | 9000.0 [1] |
| (13R,15S)-13-Methyl-16-oxa-8,9,12,22,24-pentazahexacyclo[15.6.2.16,9.112,15.02,7.021,25]heptacosa-1(24),2,4,6,17,19,21(25)-heptaene-23,27-dione | IC50 | 1000.0 [1] |
| 5-(2-Amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-tert-butylpyridine-3-sulfonamide | IC50 | 10000.0 [1] |
| 5-(2-Aminoethyl)-7-(7-(benzo[b]thiophen-2-yl)-1H-indazol-5-yl)-5H-pyrrolo[3,2-d]pyrimidin-2-amine | IC50 | 950.0 [1] |
| N-[3-[5-[2-(3-Morpholin-4-ylanilino)pyrimidin-4-yl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]-2-phenylacetamide | IC50 | 1000.0 [1] |
| 1-[5-Tert-butyl-3-[4-[2-(dimethylamino)ethyl]-5-oxo-1,4-diazepane-1-carbonyl]thiophen-2-yl]-3-(2,3-dichlorophenyl)urea | IC50 | 30000.0 [1] |
| 6-(2,4-Difluorophenyl)sulfonyl-2-(1H-indol-5-ylamino)-8-methylpyrido[2,3-d]pyrimidin-7-one | IC50 | 10000.0 [1] |
| 2-[3-(3-Piperidin-4-ylpropoxy)phenyl]-N-[4-(1H-pyrrolo[2,3-b]pyridin-3-yl)-1,3-thiazol-2-yl]acetamide | Ki | 2000.0 [1] |
| 2-[3-(Methanesulfonamido)phenyl]-N-[4-(1H-pyrrolo[2,3-b]pyridin-3-yl)-1,3-thiazol-2-yl]acetamide | Ki | 1000.0 [1] |
| 6-[4-[(5-Tert-butyl-1,2-oxazol-3-yl)carbamoylamino]phenyl]-N-[3-(dimethylamino)propyl]imidazo[2,1-b][1,3]thiazole-3-carboxamide | IC50 | 10000.0 [1] |
| 4-(2-Chloro-4-fluorophenyl)-8-(2,6-dichlorophenyl)-7-oxido-1,7-naphthyridin-7-ium | IC50 | 10000.0 [1] |
| N-Cyclohexyl-4-[6-piperazin-1-yl-4-(1H-pyrazol-5-yl)pyridin-2-yl]pyridin-2-amine | IC50 | 62.0 [1] |
| 4-[6-Piperazin-1-yl-4-(1H-pyrazol-4-yl)pyridin-2-yl]-N-propan-2-ylpyridin-2-amine | IC50 | 2.0 [1] |
| N-(Oxan-4-yl)-4-[6-piperazin-1-yl-4-(1H-pyrazol-4-yl)pyridin-2-yl]pyridin-2-amine | IC50 | 2.0 [1] |
| 2-[2-(Cyclohexylamino)pyridin-4-yl]-6-[[(3R)-pyrrolidin-3-yl]amino]pyridine-4-carboxamide | IC50 | 18.0 [1] |
| 2-[2-(Cyclohexylamino)pyridin-4-yl]-6-[[(3S)-pyrrolidin-3-yl]amino]pyridine-4-carboxamide | IC50 | 540.0 [1] |
| 2-[2-(Cyclohexylamino)pyridin-4-yl]-6-[(3R)-3-methylpiperazin-1-yl]pyridine-4-carboxamide | IC50 | 60.0 [1] |
| 2-[2-(Cyclohexylamino)pyridin-4-yl]-6-[(3S)-3-methylpiperazin-1-yl]pyridine-4-carboxamide | IC50 | 86.0 [1] |
| 2-(3-Aminopiperidin-1-yl)-6-[2-(cyclohexylamino)pyridin-4-yl]pyridine-4-carboxamide | IC50 | 168.0 [1] |
| 2-[2-(Cyclohexylamino)pyridin-4-yl]-6-(4-methylpiperazin-1-yl)pyridine-4-carboxamide | IC50 | 238.0 [1] |
| 2-[4-(Aminomethyl)piperidin-1-yl]-6-[2-(cyclohexylamino)pyridin-4-yl]pyridine-4-carboxamide | IC50 | 212.0 [1] |
| 2-[2-(Cyclohexylamino)pyridin-4-yl]-6-(3,3-dimethylpiperazin-1-yl)pyridine-4-carboxamide | IC50 | 427.0 [1] |
| N-Cyclohexyl-4-[6-piperazin-1-yl-4-(trifluoromethyl)pyridin-2-yl]pyridin-2-amine | IC50 | 101.0 [1] |
| N-Cyclohexyl-4-[4-(difluoromethyl)-6-piperazin-1-ylpyridin-2-yl]pyridin-2-amine | IC50 | 76.0 [1] |
| 2-(2-Anilinopyridin-4-yl)-6-piperazin-1-ylpyridine-4-carboxamide | IC50 | 1.0 [1] |
| 2-[2-(Oxan-4-ylamino)pyridin-4-yl]-6-piperazin-1-ylpyridine-4-carboxamide | IC50 | 9.0 [1] |
| 2-Piperazin-1-yl-6-[2-(propan-2-ylamino)pyridin-4-yl]pyridine-4-carboxamide | IC50 | 8.0 [1] |
| 2-[2-[(1-Methylpyrazol-3-yl)amino]pyridin-4-yl]-6-piperazin-1-ylpyridine-4-carboxamide | IC50 | 7.0 [1] |
| 2-[2-(2-Chloroanilino)pyridin-4-yl]-6-piperazin-1-ylpyridine-4-carboxamide | IC50 | 8.0 [1] |
| 2-[2-(Cyclopentylamino)pyridin-4-yl]-6-piperazin-1-ylpyridine-4-carboxamide | IC50 | 59.0 [1] |
| 2-[2-(Ethylamino)pyridin-4-yl]-6-piperazin-1-ylpyridine-4-carboxamide | IC50 | 31.0 [1] |
| 2-[2-(Cyclohexylamino)pyridin-4-yl]-6-piperazin-1-ylpyridine-4-carbonitrile | IC50 | 130.0 [1] |
| 2-(2-Anilinopyridin-4-yl)-6-piperazin-1-ylpyridine-4-carbonitrile | IC50 | 35.0 [1] |
| 2-[2-[(1-Methylpyrazol-3-yl)amino]pyridin-4-yl]-6-piperazin-1-ylpyridine-4-carbonitrile | IC50 | 68.0 [1] |
| N-Cyclohexyl-4-[6-piperazin-1-yl-4-(1H-pyrazol-4-yl)pyridin-2-yl]pyridin-2-amine | IC50 | 1.0 [1] |
| N-[(1R)-1-Cyanoethyl]-3-[5-[4-[(oxan-4-ylamino)methyl]phenyl]-1,2-oxazol-3-yl]benzamide | IC50 | 48.0 [1] |
| 4-Methoxy-8,14-dithia-3,5,11-triazatricyclo[7.5.0.02,7]tetradeca-1(9),2,4,6-tetraen-10-one | IC50 | 50.0 [1] |
| 4-[2-Amino-5-[4-[(dimethylamino)methyl]thiophen-2-yl]pyridin-3-yl]-2-[(Z,2R)-5,5,5-trifluoropent-3-en-2-yl]oxybenzamide | IC50 | 330.0 [1] |
| 2-[3-(3-Piperazin-1-ylpropoxy)phenyl]-N-(4-pyridin-4-yl-1,3-thiazol-2-yl)acetamide | IC50 | 1000.0 [1] |
| 6-(1,9-Diazaspiro[5.5]undecan-9-Yl)-9h-Purine | IC50 | 46000.0 [1] |
| 6-(2,9-Diazaspiro[5.5]undecan-9-Yl)-9h-Purine | IC50 | 1300.0 [1] |
| 3-(Tert-butylamino)-4-[[2-(4-pyridin-4-ylanilino)pyrimidin-4-yl]amino]cyclobut-3-ene-1,2-dione | Ki | 175.0 [1] |